WASHINGTON, DC - NOVEMBER 06: Director of Medicare and Deputy Administrator of CMS Chris Comp (L), Health and Human Services Secretary Robert F. Kennedy Jr., and Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz stand together while President Donald Trump delivers remarks on lowering drug prices in the Oval Office at the White House on November 06, 2025 in Washington, DC. Trump announced that his administration has reached agreements with drugmakers Eli Lilly and Novo Nordisk that would lower the price of some GLP-1 weight loss medications. (Photo by Andrew Harnik/Getty Images)

RFK Jr. introduces measures to end transgender treatments for minors nationwide: ‘Our children deserve better’

The federal government announced measures to end transgender treatments for children, aimed at protecting minors from what the Department of Health and Human Services (DHS) refers to as “sex-rejecting procedures,” by effectively defunding hospitals offering the treatments.

Read More RFK Jr. introduces measures to end transgender treatments for minors nationwide: ‘Our children deserve better’
Johanna Olson-Kennedy, MD. (Photo via: Children's Hospital Los Angeles)

Doctor ‘Postpones’ $10M Study Publication After Findings Show No Mental Health Improvement for Trans Kids on Puberty Blockers

After conducting a study and finding no proof that puberty blockers benefit gender dysphoric patients’ mental health, a well-known physician and trans rights activist admitted that she purposefully postponed the publishing of a $10 million taxpayer-funded study on the impact of these medications on American youth.

Read More Doctor ‘Postpones’ $10M Study Publication After Findings Show No Mental Health Improvement for Trans Kids on Puberty Blockers